Vinuri De Silva Biodesign Competition 2025

The 2025 competition was the biggest cohort since the competition originated in 2021. Featuring 118 participants across 18 teams, students from a range of degrees and universities came together to collaborate on finding solutions for an unmet clinical need. Over 10 weeks, participants engaged in weekly seminars and workshops to ultimately develop and pitch their product ideas.

​

We are extremely grateful for the continued support of our sponsors: Phillips Ormonde Fitzpatrick, MedTech Actuator, and Research Innovation Commercialisation (RIC) .
 

 

2025 Winners

 

Vinuri De Silva Graeme Clark Institute Biodesign Award: Gliopsy

RIC Innovation Prize: SonoGI

MedTech Actuator People’s Choice Award: ChromaDerm

​

 

Gliopsy

Gliopsy is a blood-based diagnostic concept designed to improve treatment decisions for patients with glioblastoma. By measuring MGMT gene methylation through a simple blood test, the team aimed to provide a faster, minimally invasive alternative to current tissue-based testing, which can take weeks to deliver results. This approach could help clinicians identify which patients are most likely to benefit from temozolomide earlier, enabling more timely and personalized treatment decisions.

 

SonoGI

SonoGI uses a sensory device attached to surgical sutures that use bowel sounds to predict and diagnose post-operative complications before symptoms appear. This wearable diagnostic tool analyses bowel sounds to proactively predict and rule out ileus, enabling significantly earlier intervention than traditional diagnosis methods. The device is self-contained and designed for continuous risk prediction.

​

ChromaDerm

Revolutionising wound dressings by turning colour into care, ChromaDerm is a colour-changing bandage that actively tells patients and caregivers when an infection is starting. By incorporating a dry reagent sheet that reacts to specific biomarkers raised during infection, the bandage changes colour to alert users to a potential developing infection. Infections caught sooner are infections treated sooner, resulting in fewer complications, fewer hospital readmissions, fewer antibiotics, and safer recoveries for patients.